Gel Agglutination Test: its application to infertile men

Area of Science:

• Reproductive Medicine
• Immunology
• Andrology

Background:

• Male infertility affects a significant portion of couples seeking fertility treatment.
• Assessing immunological factors in male infertility is crucial for diagnosis and management.
• The Gelatin Agglutination Test (GAT) has been used to detect antibodies related to infertility.

Purpose of the Study:

• To evaluate the diagnostic accuracy and reliability of the Gelatin Agglutination Test (GAT) in men attending a fertility clinic.
• To determine the prevalence of positive GAT responses in a male infertility cohort.
• To assess the correlation of GAT results with patient age and specific infertility pathologies.

Main Methods:

• Serum samples from 253 men at the Male Fertility Clinic in Nottingham were tested using the Gelatin Agglutination Test (GAT).
• Positive GAT responses and responses at a dilution of 1/32 were recorded.
• Results were analyzed for correlations with age and pathological causes of infertility.
• Test-retest reliability was assessed by re-evaluating positive GAT responses.

Main Results:

• A positive GAT response was observed in 14.2% of patients, with 11.5% showing positivity at a 1/32 dilution.
• No significant correlation was found between positive GAT results and increasing age or major infertility pathologies.
• A notable 17% of initially positive GAT responses reverted to negative upon second testing.
• The test demonstrated questionable reliability and diagnostic importance.

Conclusions:

• The Gelatin Agglutination Test (GAT) shows low diagnostic value and questionable reliability in the assessment of male infertility.
• A significant proportion of positive GAT results are transient or unreliable, limiting its clinical utility.
• Further investigation into more reliable diagnostic markers for immunological factors in male infertility is warranted.